Akela reports positive results for Fentanyl Taifun trialAkela Pharma has reported promising results from a phase IIb trial for its …
A leading heart surgeon has been appointed to ensure frontline doctors are engaged with health service reform and ensure their …
A scholarship to study for an MBA at the renowned Cranfield School of Management has been won by a pharmaceutical …
Merck Serono has seeking a broader licence for its cancer drug Erbitux in Europe to include use as a first-line …
AstraZeneca has opened its first ever clinical pharmacology unit in China, providing support for more trials to be carried out …
Xolair, a drug which helps control the most severe cases of allergic asthma, has been approved for use on the …
The European Commission has been asked to intervene in a row over a patient's access to kidney cancer drug Sutent, …
The first ever biosimilar version of blockbuster anaemia drug epoetin alfa has been approved in Europe.The drug is marketed by …
The internet loves a good scandal. From compromising celebrity videos to the latest political whisperings, whatever your interest in life, …
Advanced Life Sciences metastatic melanoma drug granted orphan statusThe FDA has granted orphan drug designation to Advanced Life Sciences for …
Atriance, a new treatment for two rare, but deadly, types of blood cancer has been approved in Europe as an …
New high blood pressure medication Rasilez has been approved in Europe, with its marketers Novartis claiming it is the first …
Health secretary Alan Johnson has confidently predicted that the NHS will not slip back into debt this year – and …
A new version of multiple sclerosis treatment Rebif, which promises to produce fewer reactions when patients inject it, is to …
A new research collaboration between Pfizer and Bristol-Myers Squibb could eventually produce innovative treatments for metabolic diseases including obesity and …
Alfacell reports promising results for cancer drugAlfacell Corporation has reported the results of a preclinical study showing that its cancer …
Interim management has been around since the 1980s, but it has come a long way since then. Twenty years ago, …
Roche's cancer drug Avastin has gained European approval as a first-line treatment for lung cancer on the back of data …
NICE has approved Biogen Idec's Tysabri for rapidly evolving severe relapsing/remitting multiple sclerosis (RRMS), using its fast-track, single technology appraisal …
Pfizer has appointed Frank D'Amelio as its new head of finance, and says he has a strong track record in …